<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31284698</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month><Day>07</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">625</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v11070625</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) infection is known to cause hand, foot, and mouth disease (HFMD), which is associated with neurological complications; however, there is currently no effective treatment for this infection. Flavonoids are a large group of naturally occurring compounds with multiple bioactivities, and the inhibitory effects of several flavonoids against EV71 have been studied in cell cultures; however, to date, there are no reported data on their effects in animal models. In this study, we confirmed the in vitro activities of eight flavonoids against EV71 infection, based on the inhibition of cytopathic effects. Moreover, these flavonoids were found to reduce viral genomic RNA replication and protein synthesis. We further demonstrated the protective efficacy of these flavonoids in newborn mice challenged with a lethal dose of EV71. Apigenin, luteolin, kaempferol, formononetin, and penduletin conferred survival protection of 88.89%, 91.67%, 88.89%, 75%, and 66.67%, respectively, from the lethal EV71 challenge. In addition, isorhamnetin provided the highest mice survival protection of 100% at a dose of 10 mg/kg. This study, to the best of our knowledge, is the first to evaluate the in vivo anti-EV7l activities of multiple flavonoids, and we accordingly identified flavonoids as potential leading compounds for anti-EV71 drug development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Wenwen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bi</LastName><ForeName>Jinpeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xinyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Xiangyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Deli</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Chunlai</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Weiheng</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-9577-7423</Identifier><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China. suweiheng@jlu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China. suweiheng@jlu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005419">Flavonoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007529">Isoflavones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044949">Kaempferols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020011">Protective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C570122">penduletin</NameOfSubstance></Chemical><Chemical><RegistryNumber>07X3IB4R4Z</RegistryNumber><NameOfSubstance UI="C047368">3-methylquercetin</NameOfSubstance></Chemical><Chemical><RegistryNumber>295DQC67BJ</RegistryNumber><NameOfSubstance UI="C007768">formononetin</NameOfSubstance></Chemical><Chemical><RegistryNumber>731P2LE49E</RegistryNumber><NameOfSubstance UI="C006552">kaempferol</NameOfSubstance></Chemical><Chemical><RegistryNumber>7V515PI7F6</RegistryNumber><NameOfSubstance UI="D047310">Apigenin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9AA5Z8PMYE</RegistryNumber><NameOfSubstance UI="C570121">chrysosplenetin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9IKM0I5T1E</RegistryNumber><NameOfSubstance UI="D011794">Quercetin</NameOfSubstance></Chemical><Chemical><RegistryNumber>KUX1ZNC9J2</RegistryNumber><NameOfSubstance UI="D047311">Luteolin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047310" MajorTopicYN="N">Apigenin</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003588" MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005419" MajorTopicYN="N">Flavonoids</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007529" MajorTopicYN="N">Isoflavones</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044949" MajorTopicYN="N">Kaempferols</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047311" MajorTopicYN="N">Luteolin</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020011" MajorTopicYN="N">Protective Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011794" MajorTopicYN="N">Quercetin</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antiviral efficacy</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">flavonoid</Keyword><Keyword MajorTopicYN="N">inhibition of cytopathic effects</Keyword><Keyword MajorTopicYN="N">isorhamnetin</Keyword><Keyword MajorTopicYN="N">survival rate</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31284698</ArticleId><ArticleId IdType="pmc">PMC6669683</ArticleId><ArticleId IdType="doi">10.3390/v11070625</ArticleId><ArticleId IdType="pii">v11070625</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Cui S., Zhao Z., Wang J. Etiology, pathogenesis, antivirals and vaccines of hand, foot, and mouth disease. Natl. Sci. Rev. 2015;2:268&#x2013;284. doi: 10.1093/nsr/nwv038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwv038</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. Fems Microbiol. Rev. 2002;26:91&#x2013;107. doi: 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., Liao Q., Viboud C., Zhang J., Sun J., Wu J.T., Chang Z., Liu F., Fang V.J., Zheng Y., et al. Hand, foot, and mouth disease in China, 2008&#x2013;2012: An epidemiological study. Lancet Infect. Dis. 2014;14:308&#x2013;318. doi: 10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 1999;341:929&#x2013;935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Q., He F., Kwang J. Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines. Viruses. 2015;7:6441&#x2013;6457. doi: 10.3390/v7122949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122949</ArticleId><ArticleId IdType="pmc">PMC4690872</ArticleId><ArticleId IdType="pubmed">26670245</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q., Wang Y., Bian L., Xu M., Liang Z. EV-A71 vaccine licensure: A first step for multivalent enterovirus vaccine to control HFMD and other severe diseases. Emerg. Microbes Infect. 2016;5:e75. doi: 10.1038/emi.2016.73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2016.73</ArticleId><ArticleId IdType="pmc">PMC5141264</ArticleId><ArticleId IdType="pubmed">27436364</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsubayashi T., Miwa Y., Takeda S., Koide M., Enoki H., Mizukami A., Matsubayashi R. Percutaneous cardiopulmonary support in a child with enterovirus 71 encephalitis. Pediatrics Int. Off. J. Jpn. Pediatric Soc. 2006;48:327&#x2013;329. doi: 10.1111/j.1442-200X.2006.02213.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-200X.2006.02213.x</ArticleId><ArticleId IdType="pubmed">16732804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.N., Yao C.T., Yeh C.N., Huang C.C., Wang S.M., Liu C.C., Wu J.M. Critical management in patients with severe enterovirus 71 infection. Pediatrics Int. Off. J. Jpn. Pediatric Soc. 2006;48:250&#x2013;256. doi: 10.1111/j.1442-200X.2006.02198.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-200X.2006.02198.x</ArticleId><ArticleId IdType="pubmed">16732789</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen M.H., Chiu C.H., Huang Y.C., Lin T.Y. Effects of lactoferrin-containing formula in the prevention of enterovirus and rotavirus infection and impact on serum cytokine levels: A randomized trial. Chang Gung Med. J. 2011;34:395&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">21880194</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Zhou F., Gu B., Ding C., Feng D., Xie F., Wang J., Zhang C., Cao Q., Deng Y., et al. In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch. Virol. 2012;157:669&#x2013;679. doi: 10.1007/s00705-011-1222-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1222-6</ArticleId><ArticleId IdType="pubmed">22245989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.N., Song Z.G., Jiang T., Shi B.S., Hu Y.W., Yuan Z.H. Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection. World J. Gastroenterol. 2010;16:201&#x2013;209. doi: 10.3748/wjg.v16.i2.201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v16.i2.201</ArticleId><ArticleId IdType="pmc">PMC2806558</ArticleId><ArticleId IdType="pubmed">20066739</ArticleId></ArticleIdList></Reference><Reference><Citation>Harborne J.B., Williams C.A. Advances in flavonoid research since 1992. Phytochemistry. 2000;55:481&#x2013;504. doi: 10.1016/S0031-9422(00)00235-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-9422(00)00235-1</ArticleId><ArticleId IdType="pubmed">11130659</ArticleId></ArticleIdList></Reference><Reference><Citation>Manthey J.A., Grohmann K., Guthrie N. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr. Med. Chem. 2001;8:135&#x2013;153. doi: 10.2174/0929867013373723.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867013373723</ArticleId><ArticleId IdType="pubmed">11172671</ArticleId></ArticleIdList></Reference><Reference><Citation>Orhan D.D., Ozcelik B., Ozgen S., Ergun F. Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol. Res. 2010;165:496&#x2013;504. doi: 10.1016/j.micres.2009.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micres.2009.09.002</ArticleId><ArticleId IdType="pubmed">19840899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv X., Qiu M., Chen D., Zheng N., Jin Y., Wu Z. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway. Antivir. Res. 2014;109:30&#x2013;41. doi: 10.1016/j.antiviral.2014.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.06.004</ArticleId><ArticleId IdType="pubmed">24971492</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Su W., Jin J., Chen J., Li X., Zhang X., Sun M., Sun S., Fan P., An D., et al. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening. Viruses. 2014;6:2778&#x2013;2795. doi: 10.3390/v6072778.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6072778</ArticleId><ArticleId IdType="pmc">PMC4113793</ArticleId><ArticleId IdType="pubmed">25036464</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai F.J., Lin C.W., Lai C.C., Lan Y.C., Lai C.H., Hung C.H., Hsueh K.C., Lin T.H., Chang H.C., Wan L., et al. Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins. Food Chem. 2011;128:312&#x2013;322. doi: 10.1016/j.foodchem.2011.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2011.03.022</ArticleId><ArticleId IdType="pubmed">25212137</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.Y., Huang S.C., Zhang Y., Lai Z.R., Kung S.H., Chang Y.S., Lin C.W. Antiviral Ability ofKalanchoe gracilisLeaf Extract against Enterovirus 71 and Coxsackievirus A16. Evid. Based Complementary Altern. Med. 2012;2012:203165. doi: 10.1155/2012/503165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/503165</ArticleId><ArticleId IdType="pmc">PMC3361180</ArticleId><ArticleId IdType="pubmed">22666293</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Zhang D., Ge M., Li Z., Jiang J., Li Y. Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE(2) expression. Virol. J. 2015;12:35. doi: 10.1186/s12985-015-0264-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0264-x</ArticleId><ArticleId IdType="pmc">PMC4351682</ArticleId><ArticleId IdType="pubmed">25890183</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q.C., Wang Y., Liu Y.P., Zhang R.Q., Li X., Su W.H., Long F., Luo X.D., Peng T. Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin. Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci. 2011;44:392&#x2013;398. doi: 10.1016/j.ejps.2011.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejps.2011.08.030</ArticleId><ArticleId IdType="pubmed">21914477</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Fan P., Jin J., Su W., An D., Xu L., Sun S., Zhang Y., Meng X., Gao F., et al. Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virol. J. 2013;10:250. doi: 10.1186/1743-422X-10-250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-250</ArticleId><ArticleId IdType="pmc">PMC3765843</ArticleId><ArticleId IdType="pubmed">23919614</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J., Xu L., Guo S., Sun S., Zhang S., Zhu C., Kong W., Jiang C. Safe and objective assay of enterovirus 71 neutralizing antibodies via pseudovirus. Chem. Res. Chin. Univ. 2012;28:91&#x2013;95.</Citation></Reference><Reference><Citation>Crouch S.P., Kozlowski R., Slater K.J., Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J. Immunol. Methods. 1993;160:81&#x2013;88. doi: 10.1016/0022-1759(93)90011-U.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(93)90011-U</ArticleId><ArticleId IdType="pubmed">7680699</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J. Viral kinetics of Enterovirus 71 in human abdomyosarcoma cells. World J. Gastroenterol. 2011;17:4135. doi: 10.3748/wjg.v17.i36.4135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v17.i36.4135</ArticleId><ArticleId IdType="pmc">PMC3203367</ArticleId><ArticleId IdType="pubmed">22039330</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhuis M., van Maarseveen N., Schuurman R., Verkuijlen S., de Vos M., Hendriksen K., van Loon A.M. Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR. J. Clin. Microbiol. 2002;40:3666&#x2013;3670. doi: 10.1128/JCM.40.10.3666-3670.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.10.3666-3670.2002</ArticleId><ArticleId IdType="pmc">PMC130891</ArticleId><ArticleId IdType="pubmed">12354863</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W., Wu Y., Bi J., Lu X., Hou A., Zhou Y., Sun B., Kong W., Barbier J., Cintrat J.C., et al. Antiviral effects of Retro-2(cycl) and Retro-2.1 against Enterovirus 71 in vitro and in vivo. Antivir. Res. 2017;144:311&#x2013;321. doi: 10.1016/j.antiviral.2017.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.07.001</ArticleId><ArticleId IdType="pubmed">28688753</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Song Z., Qin B., Zhang X., Chen L., Hu Y., Yuan Z. Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: Evaluation of antiviral efficacy in a murine infection model. Antivir. Res. 2013;97:264&#x2013;269. doi: 10.1016/j.antiviral.2012.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.029</ArticleId><ArticleId IdType="pubmed">23295352</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya Y., Shimizu M., Hiyama Y., Itoh K., Hashimoto Y., Nakayama M., Horie T., Morita N. Antiviral activity of natural occurring flavonoids in vitro. Chem. Pharm. Bull. 1985;33:3881&#x2013;3886. doi: 10.1248/cpb.33.3881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/cpb.33.3881</ArticleId><ArticleId IdType="pubmed">4092287</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone Ferreyra M.L., Rius S.P., Casati P. Flavonoids: Biosynthesis, biological functions, and biotechnological applications. Front. Plant Sci. 2012;3:222. doi: 10.3389/fpls.2012.00222.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpls.2012.00222</ArticleId><ArticleId IdType="pmc">PMC3460232</ArticleId><ArticleId IdType="pubmed">23060891</ArticleId></ArticleIdList></Reference><Reference><Citation>Castrillo J.L., Vanden Berghe D., Carrasco L. 3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis. Virology. 1986;152:219&#x2013;227. doi: 10.1016/0042-6822(86)90386-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(86)90386-7</ArticleId><ArticleId IdType="pubmed">3012868</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C., Lai J.K., Sam I.C., Chan Y. Recent developments in antiviral agents against enterovirus 71 infection. J. Biomed. Sci. 2014;21:14. doi: 10.1186/1423-0127-21-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-14</ArticleId><ArticleId IdType="pmc">PMC3924904</ArticleId><ArticleId IdType="pubmed">24521134</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Z.P., Peng Z.Y., Peng M.J., Yan W.B., Ouyang Y.Z., Zhu H.L. Flavonoids health benefits and their molecular mechanism. Mini Rev. Med. Chem. 2011;11:169&#x2013;177. doi: 10.2174/138955711794519546.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138955711794519546</ArticleId><ArticleId IdType="pubmed">21222576</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrijsen R., Everaert L., Boeye A. Antiviral activity of flavones and potentiation by ascorbate. J. Gen. Virol. 1988;69:1749&#x2013;1751. doi: 10.1099/0022-1317-69-7-1749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-69-7-1749</ArticleId><ArticleId IdType="pubmed">2839607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesan S., Faris A.N., Comstock A.T., Wang Q., Nanua S., Hershenson M.B., Sajjan U.S. Quercetin inhibits rhinovirus replication in vitro and in vivo. Antivir. Res. 2012;94:258&#x2013;271. doi: 10.1016/j.antiviral.2012.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.03.005</ArticleId><ArticleId IdType="pmc">PMC3360794</ArticleId><ArticleId IdType="pubmed">22465313</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian S., Fan W., Qian P., Zhang D., Wei Y., Chen H., Li X. Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity. Viruses. 2015;7:1613&#x2013;1626. doi: 10.3390/v7041613.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7041613</ArticleId><ArticleId IdType="pmc">PMC4411668</ArticleId><ArticleId IdType="pubmed">25835532</ArticleId></ArticleIdList></Reference><Reference><Citation>Murali K.S., Sivasubramanian S., Vincent S., Murugan S.B., Giridaran B., Dinesh S., Gunasekaran P., Krishnasamy K., Sathishkumar R. Anti&#x2014;chikungunya activity of luteolin and apigenin rich fraction from Cynodon dactylon. Asian Pac. J. Trop. Med. 2015;8:352&#x2013;358. doi: 10.1016/S1995-7645(14)60343-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1995-7645(14)60343-6</ArticleId><ArticleId IdType="pubmed">26003593</ArticleId></ArticleIdList></Reference><Reference><Citation>Keramagi A.R., Skariyachan S. Prediction of binding potential of natural leads against the prioritized drug targets of chikungunya and dengue viruses by computational screening. 3 Biotech. 2018;8:274. doi: 10.1007/s13205-018-1303-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13205-018-1303-2</ArticleId><ArticleId IdType="pmc">PMC5971020</ArticleId><ArticleId IdType="pubmed">29868312</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh A., Desai A., Ravi V., Narayanappa G., Tyagi B.K. Chikungunya Virus Interacts with Heat Shock Cognate 70 Protein to Facilitate Its Entry into Mosquito Cell Line. Intervirology. 2017;60:247&#x2013;262. doi: 10.1159/000489308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000489308</ArticleId><ArticleId IdType="pubmed">29953983</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata C., Ohno M., Otsuka M., Kishikawa T., Goto K., Muroyama R., Kato N., Yoshikawa T., Takata A., Koike K. The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels. Virology. 2014;462:42&#x2013;48. doi: 10.1016/j.virol.2014.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2014.05.024</ArticleId><ArticleId IdType="pubmed">25092460</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas A., Del Campo J.A., Clement S., Lemasson M., Garcia-Valdecasas M., Gil-Gomez A., Ranchal I., Bartosch B., Bautista J.D., Rosenberg A.R., et al. Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets. Sci. Rep. 2016;6:31777. doi: 10.1038/srep31777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31777</ArticleId><ArticleId IdType="pmc">PMC4992894</ArticleId><ArticleId IdType="pubmed">27546480</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawas U.W., Abou El-Kassem L.T., Shaher F., Al-Farawati R. In vitro inhibition of Hepatitis C virus protease and antioxidant by flavonoid glycosides from the Saudi costal plant Sarcocornia fruticosa. Nat. Prod. Res. 2018;32:1&#x2013;8. doi: 10.1080/14786419.2018.1477153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14786419.2018.1477153</ArticleId><ArticleId IdType="pubmed">29897265</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng M., Watanabe S., Chan K.W.K., He Q., Zhao Y., Zhang Z., Lai X., Luo D., Vasudevan S.G., Li G. Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin. Antivir. Res. 2017;143:176&#x2013;185. doi: 10.1016/j.antiviral.2017.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.03.026</ArticleId><ArticleId IdType="pubmed">28389141</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W., Qian S., Qian P., Li X. Antiviral activity of luteolin against Japanese encephalitis virus. Virus Res. 2016;220:112&#x2013;116. doi: 10.1016/j.virusres.2016.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2016.04.021</ArticleId><ArticleId IdType="pubmed">27126774</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Wu Z., Du J., Hu Y., Liu L., Yang F., Jin Q. Anti-Japanese-encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics. PLoS ONE. 2012;7:e30259. doi: 10.1371/journal.pone.0030259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030259</ArticleId><ArticleId IdType="pmc">PMC3262791</ArticleId><ArticleId IdType="pubmed">22276167</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhargava S., Patel T., Gaikwad R., Patil U.K., Gayen S. Identification of structural requirements and prediction of inhibitory activity of natural flavonoids against Zika virus through molecular docking and Monte Carlo based QSAR Simulation. Nat. Prod. Res. 2017;31:1&#x2013;7. doi: 10.1080/14786419.2017.1413574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14786419.2017.1413574</ArticleId><ArticleId IdType="pubmed">29241370</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>